Author:
Ashburn Ted T.,Gupta Meera S.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference7 articles.
1. Cowen, S. G. Therapeutic Categories Outlook (SG Cowen, 2005).
2. Campos, G. M. et al. The pattern of esophageal acid exposure in gastroesophageal reflux disease influences the severity of disease. Arch Surg. 134, 882–888 (1999).
3. Orr, W. C. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. Eur. J. Gastroenterol. Hepatol. 17, 113–120 (2005).
4. Duenwald, M. The Consumer: heartburn relief, from Aciphex to Zantac. The New York Times (22 Feb 2005).
5. Tonini, M., Giorgio, R. D. & Ponti, F. D. Progress with novel pharmacological strategies for gastro-oesophageal reflux disease. Drugs 64, 347–361 (2004).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献